Cell Receptor also provides insights into pharmacologically useful substances that can inhibit these mechanisms. Based on this, methods were developed for the prevention of cancer metastases and for the suppression of undesired proliferative processes, for example in the immune system. The company owns significant intellectual property for this. Our patents concern the blocking of the transport process by substances that we have found to be effective. We are convinced that the clinical demand will be quite substantial. Cell Receptor is now planning a clinical trial in collaboration with a renowned hospital as proof of concept. In the sense of repurposing, a substance that we have recognized as effective and that has already been approved will be used.
| Website | http://www.cellreceptor.ch |
| Revenue | $2 million |
| Employees | View employees |
| Founded | 2010 |
| Address | S Trust Services Sa 30a C/o L &, Geneva, Geneva 1208, CH |
| Technologies |
JavaScript
,
HTML
,
Font Awesome
+4 more
(view full list)
|
| Industry | Telecommunications General, Biotechnology, Telecommunications, Science and Engineering, Life Science, Medical, Health Care, Pharmaceutical |
| Competitors | Johnson & Johnson, Roche, Thermo Fisher Scientific, AbbVie, Pfizer, Genentech, Merck Group, Illumina, Bio-Rad Laboratories, Lilly India +42 more (view full list) |
| SIC | SIC Code 48 Companies, SIC Code 481 Companies |
| NAICS | NAICS Code 51 Companies, NAICS Code 51731 Companies, NAICS Code 517312 Companies, NAICS Code 517 Companies, NAICS Code 5173 Companies |
Looking for a particular Cell Receptor employee's phone or email?
Cell Receptor Questions
The Cell Receptor annual revenue was $2 million in 2026.
Cell Receptor is based in Geneva, Geneva.
The NAICS codes for Cell Receptor are [51, 51731, 517312, 517, 5173].
The SIC codes for Cell Receptor are [48, 481].
